Abbott (ABT) stock price declined slightly, but company's financials and growth outlook are positive.

From Nasdaq: 2024-11-29 17:50:06

Abbott (ABT) closed at $118.77, down -0.15%, underperforming S&P 500. In the past month, ABT gained 4.92%, while the Medical sector lost 2.27%. Analysts expect an EPS of $1.34 and revenue of $11.03 billion for the upcoming earnings report, with full-year estimates showing positive growth.

Investors should monitor ABT’s recent analyst revisions, as positive changes correlate with stock price performance. The Zacks Rank system, with ABT currently at #3 (Hold), historically outperforms. ABT trades at a Forward P/E ratio of 25.47, a discount compared to the industry average of 26.43.

Nuclear energy is gaining traction globally, with US and 21 other countries committing to tripling nuclear energy capacities. This shift could lead to significant profits for nuclear-related stocks. Explore the potential in the free report “Atomic Opportunity: Nuclear Energy’s Comeback” and discover top stocks positioned to benefit from this trend.



Read more at Nasdaq: Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors